Frazier-Life-Sciences-Management-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "ASND",
  "TRVI",
  "ALKS",
  "KRYS",
  "NAMS",
  "ARQT",
  "RVMD",
  "ORIC",
  "ACAD",
  "MREO",
  "RCKT",
  "ALLO",
  "SLN",
  "IMTX",
  "SVRA",
  "MIRM",
  "PHAT",
  "ADVM",
  "AUTL",
  "TARS",
  "KALV",
  "MGNX",
  "LXEO",
  null,
  "PVLA",
  null,
  "RNA",
  "AGIO",
  "MBX",
  "RYTM",
  "SLNO",
  "COGT",
  "DYN",
  "ELEV",
  "ERAS",
  "IMCR",
  "DSGN",
  "HLVX",
  "VRNA",
  "ZLAB",
  "ORKA",
  "RARE",
  "PCVX",
  "BBIO",
  "CGON",
  "IRON"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 47
Total Value: 2187908599
Accession Number: 0001892134-25-000005
Form Type: 13F-HR
CIK: frazier-life-sciences-management-lp
Manager Name: Frazier-Life-Sciences-Management-Lp

Data Enrichment

96% identified

45 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

47 positions • $2.2B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 3 of 3

Sort by:

Cogent Biosciences, Inc.

COGT|19240Q201

Shares:936.6K

Value:$5.6M

% of Portfolio:0.3% ($5.6M/$2.2B)

Adverum Biotechnologies, Inc.

ADVM|00773U207

Shares:1.1M

Value:$4.7M

% of Portfolio:0.2% ($4.7M/$2.2B)

N62509117

Shares:500.3K

Value:$4.5M

% of Portfolio:0.2% ($4.5M/$2.2B)

MACROGENICS INC

MGNX|556099109

Shares:3.2M

Value:$4.0M

% of Portfolio:0.2% ($4.0M/$2.2B)

Lexeo Therapeutics, Inc.

LXEO|52886X107

Shares:955.5K

Value:$3.3M

% of Portfolio:0.2% ($3.3M/$2.2B)

Silence Therapeutics plc

SLN|82686Q101

Shares:1.1M

Value:$3.2M

% of Portfolio:0.1% ($3.2M/$2.2B)

Elevation Oncology, Inc.

ELEV|28623U101

Shares:6.0M

Value:$1.6M

% of Portfolio:0.1% ($1.6M/$2.2B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Cogent Biosciences, Inc.(COGTcusip19240Q201)	936.6K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$5.6M	0.3% ($5.6M/$2.2B)	QoQ -23.20% (-$1.7M) YoY -10.86% (-$683.7K)
Adverum Biotechnologies, Inc.(ADVMcusip00773U207)	1.1M	QoQ 0.00% (-0) YoY NEW(+1.1M)	All Managers (Combined)	$4.7M	0.2% ($4.7M/$2.2B)	QoQ -6.42% (-$320.8K) YoY NEW(+$4.7M)
(cusipN62509117)✕	500.3K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$4.5M	0.2% ($4.5M/$2.2B)	QoQ -36.91% (-$2.6M) YoY -18.56% (-$1.0M)
MACROGENICS INC(MGNXcusip556099109)	3.2M	QoQ 0.00% (-0) YoY +28.48% (-704.0K)	All Managers (Combined)	$4.0M	0.2% ($4.0M/$2.2B)	QoQ -60.92% (-$6.3M) YoY -88.91% (-$32.4M)
Lexeo Therapeutics, Inc.(LXEOcusip52886X107)	955.5K	QoQ 0.00% (-0) YoY NEW(+955.5K)	All Managers (Combined)	$3.3M	0.2% ($3.3M/$2.2B)	QoQ -47.26% (-$3.0M) YoY NEW(+$3.3M)
Silence Therapeutics plc(SLNcusip82686Q101)	1.1M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$3.2M	0.1% ($3.2M/$2.2B)	QoQ -59.01% (-$4.7M) YoY -86.94% (-$21.6M)
Elevation Oncology, Inc.(ELEVcusip28623U101)	6.0M	QoQ 0.00% (-0) YoY NEW(+6.0M)	All Managers (Combined)	$1.6M	0.1% ($1.6M/$2.2B)	QoQ -53.94% (-$1.8M) YoY NEW(+$1.6M)